{"id":"W4397041045","doi":"10.1681/asn.20233411s18a","title":"eGFR Decline in Patients with IgA Nephropathy Treated with Nefecon or Placebo: Results from the 2-Year NefIgArd Phase 3 Trial","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Placebo; Nephropathy; Medicine; Internal medicine; Gastroenterology; Pathology; Endocrinology; Diabetes mellitus; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00260559,0.0008639379,0.002342249,0.0002018477,0.0002925168,0.001021226,0.000519362,0.001306331,0.002402955],"category_scores_gemma":[0.001846373,0.0002603713,0.002251303,0.0002970409,0.0004910378,0.0008576697,0.0002488372,0.001958089,0.0003293024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000586329,"about_ca_system_score_gemma":0.00059209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005286557,"about_ca_topic_score_gemma":0.001248417,"domain_scores_codex":[0.9992731,0.0004053669,0.00004956657,0.000101079,0.00006802061,0.0001028404],"domain_scores_gemma":[0.998937,0.0003409458,0.0003039667,0.00009907613,0.00007652644,0.0002424752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9667962,0.003595256,0.006388751,0.0003695054,0.001832524,0.00007633535,0.00006993199,0.0003701547,0.002547831,0.00006120104,0.0008870698,0.01700529],"study_design_scores_gemma":[0.7628135,0.1659228,0.06475036,0.0001064432,0.002383451,0.0002312832,0.00006579563,0.0008154869,0.0009010748,0.0002368628,0.001734017,0.00003892426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926983,0.00476386,0.0001833705,0.0003082713,0.00009121723,0.0003209255,0.0006684532,0.00002541584,0.0009402455],"genre_scores_gemma":[0.9959468,0.001193417,0.0002282601,0.0004880474,0.0001336866,0.000373506,0.001046291,0.000007003882,0.0005830944],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00260559,"threshold_uncertainty_score":0.01377982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01759219747045372,"score_gpt":0.2851356610249535,"score_spread":0.2675434635544998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}